Product Information
TRAZODONE 150 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0864 per EA under NDC 00904721261. Its NADAC has been published 206 times since Oct 26, 2022.
FDA first approved this application on Oct 10, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904721261
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRAZODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205253FDA Approved
10/10/2017
TE Code
AB
On Market Since
12/11/2017
Pharmacological Classes
Price Statistics
The NADAC for TRAZODONE 150 MG TABLET has been published 206 times since Oct 26, 2022, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0864 per EA |
|---|---|
| All-time high | $0.1406 (Mar 15, 2023) |
| All-time low | $0.0864 (Sep 23, 2026) |
| 52-week high | $0.1061 |
| 52-week low | $0.0864 |
| Median price | $0.1174 |
| Average price | $0.1130 |
| Largest weekly change | +23.9% (Feb 22, 2023) |
| Weeks tracked | 206 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trazodone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAZODONE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRAZODONE 150 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0864 per EA (NDC 00904721261), effective Sep 30, 2026.
How has the price of TRAZODONE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRAZODONE 150 MG TABLET has declined 26.8%. It has been tracked across 206 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for TRAZODONE 150 MG TABLET?
Since Oct 26, 2022, the NADAC for TRAZODONE 150 MG TABLET has ranged from a low of $0.0864 (Sep 23, 2026) to a high of $0.1406 (Mar 15, 2023), with a median of $0.1174 per EA.
Are there cheaper alternatives to TRAZODONE 150 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRAZODONE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRAZODONE 150 MG TABLET?
TRAZODONE 150 MG TABLET (NDC 00904721261) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.